1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adoptive Cellular Immunotherapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 TIL
1.2.3 LAK
1.2.4 CAR-T
1.2.5 TCR-T
1.2.6 CIK
1.2.7 NK
1.2.8 DC
1.2.9 Other
1.3 Market by Application
1.3.1 Global Adoptive Cellular Immunotherapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Cancer Hospital
1.3.4 Centers for Disease Control and Prevention
1.3.5 Rehabilitation Center
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered 2 Global Growth Trends
2.1 Global Adoptive Cellular Immunotherapy Market Perspective (2017-2028)
2.2 Adoptive Cellular Immunotherapy Growth Trends by Region
2.2.1 Adoptive Cellular Immunotherapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Adoptive Cellular Immunotherapy Historic Market Size by Region (2017-2022)
2.2.3 Adoptive Cellular Immunotherapy Forecasted Market Size by Region (2023-2028)
2.3 Adoptive Cellular Immunotherapy Market Dynamics
2.3.1 Adoptive Cellular Immunotherapy Industry Trends
2.3.2 Adoptive Cellular Immunotherapy Market Drivers
2.3.3 Adoptive Cellular Immunotherapy Market Challenges
2.3.4 Adoptive Cellular Immunotherapy Market Restraints 3 Competition Landscape by Key Players
3.1 Global Top Adoptive Cellular Immunotherapy Players by Revenue
3.1.1 Global Top Adoptive Cellular Immunotherapy Players by Revenue (2017-2022)
3.1.2 Global Adoptive Cellular Immunotherapy Revenue Market Share by Players (2017-2022)
3.2 Global Adoptive Cellular Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Adoptive Cellular Immunotherapy Revenue
3.4 Global Adoptive Cellular Immunotherapy Market Concentration Ratio
3.4.1 Global Adoptive Cellular Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adoptive Cellular Immunotherapy Revenue in 2021
3.5 Adoptive Cellular Immunotherapy Key Players Head office and Area Served
3.6 Key Players Adoptive Cellular Immunotherapy Product Solution and Service
3.7 Date of Enter into Adoptive Cellular Immunotherapy Market
3.8 Mergers & Acquisitions, Expansion Plans 4 Adoptive Cellular Immunotherapy Breakdown Data by Type
4.1 Global Adoptive Cellular Immunotherapy Historic Market Size by Type (2017-2022)
4.2 Global Adoptive Cellular Immunotherapy Forecasted Market Size by Type (2023-2028) 5 Adoptive Cellular Immunotherapy Breakdown Data by Application
5.1 Global Adoptive Cellular Immunotherapy Historic Market Size by Application (2017-2022)
5.2 Global Adoptive Cellular Immunotherapy Forecasted Market Size by Application (2023-2028) 6 North America
6.1 North America Adoptive Cellular Immunotherapy Market Size (2017-2028)
6.2 North America Adoptive Cellular Immunotherapy Market Size by Type
6.2.1 North America Adoptive Cellular Immunotherapy Market Size by Type (2017-2022)
6.2.2 North America Adoptive Cellular Immunotherapy Market Size by Type (2023-2028)
6.2.3 North America Adoptive Cellular Immunotherapy Market Share by Type (2017-2028)
6.3 North America Adoptive Cellular Immunotherapy Market Size by Application
6.3.1 North America Adoptive Cellular Immunotherapy Market Size by Application (2017-2022)
6.3.2 North America Adoptive Cellular Immunotherapy Market Size by Application (2023-2028)
6.3.3 North America Adoptive Cellular Immunotherapy Market Share by Application (2017-2028)
6.4 North America Adoptive Cellular Immunotherapy Market Size by Country
6.4.1 North America Adoptive Cellular Immunotherapy Market Size by Country (2017-2022)
6.4.2 North America Adoptive Cellular Immunotherapy Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada 7 Europe
7.1 Europe Adoptive Cellular Immunotherapy Market Size (2017-2028)
7.2 Europe Adoptive Cellular Immunotherapy Market Size by Type
7.2.1 Europe Adoptive Cellular Immunotherapy Market Size by Type (2017-2022)
7.2.2 Europe Adoptive Cellular Immunotherapy Market Size by Type (2023-2028)
7.2.3 Europe Adoptive Cellular Immunotherapy Market Share by Type (2017-2028)
7.3 Europe Adoptive Cellular Immunotherapy Market Size by Application
7.3.1 Europe Adoptive Cellular Immunotherapy Market Size by Application (2017-2022)
7.3.2 Europe Adoptive Cellular Immunotherapy Market Size by Application (2023-2028)
7.3.3 Europe Adoptive Cellular Immunotherapy Market Share by Application (2017-2028)
7.4 Europe Adoptive Cellular Immunotherapy Market Size by Country
7.4.1 Europe Adoptive Cellular Immunotherapy Market Size by Country (2017-2022)
7.4.2 Europe Adoptive Cellular Immunotherapy Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries 8 Asia-Pacific
8.1 Asia-Pacific Adoptive Cellular Immunotherapy Market Size (2017-2028)
8.2 Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Type
8.2.1 Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Adoptive Cellular Immunotherapy Market Share by Type (2017-2028)
8.3 Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Application
8.3.1 Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Adoptive Cellular Immunotherapy Market Share by Application (2017-2028)
8.4 Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Region
8.4.1 Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia 9 Latin America
9.1 Latin America Adoptive Cellular Immunotherapy Market Size (2017-2028)
9.2 Latin America Adoptive Cellular Immunotherapy Market Size by Type
9.2.1 Latin America Adoptive Cellular Immunotherapy Market Size by Type (2017-2022)
9.2.2 Latin America Adoptive Cellular Immunotherapy Market Size by Type (2023-2028)
9.2.3 Latin America Adoptive Cellular Immunotherapy Market Share by Type (2017-2028)
9.3 Latin America Adoptive Cellular Immunotherapy Market Size by Application
9.3.1 Latin America Adoptive Cellular Immunotherapy Market Size by Application (2017-2022)
9.3.2 Latin America Adoptive Cellular Immunotherapy Market Size by Application (2023-2028)
9.3.3 Latin America Adoptive Cellular Immunotherapy Market Share by Application (2017-2028)
9.4 Latin America Adoptive Cellular Immunotherapy Market Size by Country
9.4.1 Latin America Adoptive Cellular Immunotherapy Market Size by Country (2017-2022)
9.4.2 Latin America Adoptive Cellular Immunotherapy Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil 10 Middle East & Africa
10.1 Middle East & Africa Adoptive Cellular Immunotherapy Market Size (2017-2028)
10.2 Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Type
10.2.1 Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Adoptive Cellular Immunotherapy Market Share by Type (2017-2028)
10.3 Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Application
10.3.1 Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Adoptive Cellular Immunotherapy Market Share by Application (2017-2028)
10.4 Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Country
10.4.1 Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE 11 Key Players Profiles
11.1 Amgen Inc
11.1.1 Amgen Inc Company Details
11.1.2 Amgen Inc Business Overview
11.1.3 Amgen Inc Adoptive Cellular Immunotherapy Introduction
11.1.4 Amgen Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.1.5 Amgen Inc Recent Developments
11.2 Autolus Therapeutics Plc
11.2.1 Autolus Therapeutics Plc Company Details
11.2.2 Autolus Therapeutics Plc Business Overview
11.2.3 Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Introduction
11.2.4 Autolus Therapeutics Plc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.2.5 Autolus Therapeutics Plc Recent Developments
11.3 Beijing Immunochina Medical Science & Technology Co Ltd
11.3.1 Beijing Immunochina Medical Science & Technology Co Ltd Company Details
11.3.2 Beijing Immunochina Medical Science & Technology Co Ltd Business Overview
11.3.3 Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular Immunotherapy Introduction
11.3.4 Beijing Immunochina Medical Science & Technology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.3.5 Beijing Immunochina Medical Science & Technology Co Ltd Recent Developments
11.4 Bellicum Pharmaceuticals Inc
11.4.1 Bellicum Pharmaceuticals Inc Company Details
11.4.2 Bellicum Pharmaceuticals Inc Business Overview
11.4.3 Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Introduction
11.4.4 Bellicum Pharmaceuticals Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.4.5 Bellicum Pharmaceuticals Inc Recent Developments
11.5 Bristol-Myers Squibb Co
11.5.1 Bristol-Myers Squibb Co Company Details
11.5.2 Bristol-Myers Squibb Co Business Overview
11.5.3 Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Introduction
11.5.4 Bristol-Myers Squibb Co Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.5.5 Bristol-Myers Squibb Co Recent Developments
11.6 bluebird bio Inc
11.6.1 bluebird bio Inc Company Details
11.6.2 bluebird bio Inc Business Overview
11.6.3 bluebird bio Inc Adoptive Cellular Immunotherapy Introduction
11.6.4 bluebird bio Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.6.5 bluebird bio Inc Recent Developments
11.7 CARsgen Therapeutics Ltd
11.7.1 CARsgen Therapeutics Ltd Company Details
11.7.2 CARsgen Therapeutics Ltd Business Overview
11.7.3 CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Introduction
11.7.4 CARsgen Therapeutics Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.7.5 CARsgen Therapeutics Ltd Recent Developments
11.8 Celgene Corp
11.8.1 Celgene Corp Company Details
11.8.2 Celgene Corp Business Overview
11.8.3 Celgene Corp Adoptive Cellular Immunotherapy Introduction
11.8.4 Celgene Corp Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.8.5 Celgene Corp Recent Developments
11.9 Cell Medica Ltd
11.9.1 Cell Medica Ltd Company Details
11.9.2 Cell Medica Ltd Business Overview
11.9.3 Cell Medica Ltd Adoptive Cellular Immunotherapy Introduction
11.9.4 Cell Medica Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.9.5 Cell Medica Ltd Recent Developments
11.10 Cellular Biomedicine Group Inc
11.10.1 Cellular Biomedicine Group Inc Company Details
11.10.2 Cellular Biomedicine Group Inc Business Overview
11.10.3 Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Introduction
11.10.4 Cellular Biomedicine Group Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.10.5 Cellular Biomedicine Group Inc Recent Developments
11.11 Celularity Inc
11.11.1 Celularity Inc Company Details
11.11.2 Celularity Inc Business Overview
11.11.3 Celularity Inc Adoptive Cellular Immunotherapy Introduction
11.11.4 Celularity Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.11.5 Celularity Inc Recent Developments
11.12 Celyad SA
11.12.1 Celyad SA Company Details
11.12.2 Celyad SA Business Overview
11.12.3 Celyad SA Adoptive Cellular Immunotherapy Introduction
11.12.4 Celyad SA Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.12.5 Celyad SA Recent Developments
11.13 Daiichi Sankyo Co Ltd
11.13.1 Daiichi Sankyo Co Ltd Company Details
11.13.2 Daiichi Sankyo Co Ltd Business Overview
11.13.3 Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Introduction
11.13.4 Daiichi Sankyo Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.13.5 Daiichi Sankyo Co Ltd Recent Developments
11.14 Fosun Pharmaceutical AG
11.14.1 Fosun Pharmaceutical AG Company Details
11.14.2 Fosun Pharmaceutical AG Business Overview
11.14.3 Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Introduction
11.14.4 Fosun Pharmaceutical AG Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.14.5 Fosun Pharmaceutical AG Recent Developments
11.15 Gilead Sciences Inc
11.15.1 Gilead Sciences Inc Company Details
11.15.2 Gilead Sciences Inc Business Overview
11.15.3 Gilead Sciences Inc Adoptive Cellular Immunotherapy Introduction
11.15.4 Gilead Sciences Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.15.5 Gilead Sciences Inc Recent Developments
11.16 Guangzhou Anjie Biomedical Technology Co Ltd
11.16.1 Guangzhou Anjie Biomedical Technology Co Ltd Company Details
11.16.2 Guangzhou Anjie Biomedical Technology Co Ltd Business Overview
11.16.3 Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Introduction
11.16.4 Guangzhou Anjie Biomedical Technology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.16.5 Guangzhou Anjie Biomedical Technology Co Ltd Recent Developments
11.17 Hangzhou Converd Co Ltd
11.17.1 Hangzhou Converd Co Ltd Company Details
11.17.2 Hangzhou Converd Co Ltd Business Overview
11.17.3 Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Introduction
11.17.4 Hangzhou Converd Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.17.5 Hangzhou Converd Co Ltd Recent Developments
11.18 Hebei Senlang Biotechnology Inc Ltd
11.18.1 Hebei Senlang Biotechnology Inc Ltd Company Details
11.18.2 Hebei Senlang Biotechnology Inc Ltd Business Overview
11.18.3 Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Introduction
11.18.4 Hebei Senlang Biotechnology Inc Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.18.5 Hebei Senlang Biotechnology Inc Ltd Recent Developments
11.19 HRAIN Biotechnology Co Ltd
11.19.1 HRAIN Biotechnology Co Ltd Company Details
11.19.2 HRAIN Biotechnology Co Ltd Business Overview
11.19.3 HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Introduction
11.19.4 HRAIN Biotechnology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.19.5 HRAIN Biotechnology Co Ltd Recent Developments
11.20 Juno Therapeutics Inc
11.20.1 Juno Therapeutics Inc Company Details
11.20.2 Juno Therapeutics Inc Business Overview
11.20.3 Juno Therapeutics Inc Adoptive Cellular Immunotherapy Introduction
11.20.4 Juno Therapeutics Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.20.5 Juno Therapeutics Inc Recent Developments
11.21 Kite Pharma Inc
11.21.1 Kite Pharma Inc Company Details
11.21.2 Kite Pharma Inc Business Overview
11.21.3 Kite Pharma Inc Adoptive Cellular Immunotherapy Introduction
11.21.4 Kite Pharma Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.21.5 Kite Pharma Inc Recent Developments
11.22 Nanjing Legend Biotech Co Ltd
11.22.1 Nanjing Legend Biotech Co Ltd Company Details
11.22.2 Nanjing Legend Biotech Co Ltd Business Overview
11.22.3 Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Introduction
11.22.4 Nanjing Legend Biotech Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.22.5 Nanjing Legend Biotech Co Ltd Recent Developments
11.23 NantKwest Inc
11.23.1 NantKwest Inc Company Details
11.23.2 NantKwest Inc Business Overview
11.23.3 NantKwest Inc Adoptive Cellular Immunotherapy Introduction
11.23.4 NantKwest Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.23.5 NantKwest Inc Recent Developments
11.24 Nkarta Inc
11.24.1 Nkarta Inc Company Details
11.24.2 Nkarta Inc Business Overview
11.24.3 Nkarta Inc Adoptive Cellular Immunotherapy Introduction
11.24.4 Nkarta Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.24.5 Nkarta Inc Recent Developments
11.25 Novartis AG
11.25.1 Novartis AG Company Details
11.25.2 Novartis AG Business Overview
11.25.3 Novartis AG Adoptive Cellular Immunotherapy Introduction
11.25.4 Novartis AG Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.25.5 Novartis AG Recent Developments
11.26 Ono Pharmaceutical Co Ltd
11.26.1 Ono Pharmaceutical Co Ltd Company Details
11.26.2 Ono Pharmaceutical Co Ltd Business Overview
11.26.3 Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Introduction
11.26.4 Ono Pharmaceutical Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.26.5 Ono Pharmaceutical Co Ltd Recent Developments
11.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
11.27.1 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Details
11.27.2 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview
11.27.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Introduction
11.27.4 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.27.5 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Developments
11.28 Sorrento Therapeutics Inc
11.28.1 Sorrento Therapeutics Inc Company Details
11.28.2 Sorrento Therapeutics Inc Business Overview
11.28.3 Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Introduction
11.28.4 Sorrento Therapeutics Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.28.5 Sorrento Therapeutics Inc Recent Developments
11.29 Takara Bio Inc
11.29.1 Takara Bio Inc Company Details
11.29.2 Takara Bio Inc Business Overview
11.29.3 Takara Bio Inc Adoptive Cellular Immunotherapy Introduction
11.29.4 Takara Bio Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
11.29.5 Takara Bio Inc Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
